TF
IONS icon

TimeScale Financial’s Ionis Pharmaceuticals IONS Stock Holding History

TimeScale Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$451 Buy
+11
New +$423 ﹤0.01% 578

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

TimeScale Financial's IONS Position: Q2 2023 in Review

TimeScale Financial opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2023: 11 shares worth $451. The stake represents ﹤0.01% of the portfolio and ranks #578 among its holdings.

304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

  • TimeScale Financial held 11 shares of Ionis Pharmaceuticals worth $451 as of Q2 2023.
  • Ionis Pharmaceuticals was a new TimeScale Financial position in Q2 2023.
  • Ionis Pharmaceuticals made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #578 holding.
  • 304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.